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Abstract
Background: General practitioners (GPs) in Norway increasingly use spirometry diagnostically as well as in follow
up of patients with respiratory complaints, but little is known about their skills and knowledge in this area. The aim
of the present study was to investigate how GPs interpret a case history and spirometry recordings of a patient
with chronic obstructive pulmonary disease (COPD), and their knowledge about their own spirometer.
Methods: A web-based survey, consisting of a case history and spirometry recordings of a patient with COPD, was
distributed to the 4700 members of the Norwegian GP Association. In addition to background information about
themselves and their spirometer, topics included whether they requested, and how they interpreted, a spirometry
reversibility-test, identification of the of most likely diagnosis, and recognition of the spirometry parameters used to
diagnose COPD and grade airway obstruction. Immediate feedback was provided for educational purposes.
Results: Six hundred thirty GPs responded. Twenty six percent would not request a reversibility test, but 81%
identified COPD as the most likely diagnosis. Less than 50% correctly identified the spirometry parameters used for
diagnosis of COPD and grading the airway obstruction. One in five (21%) did not know which spirometer was used
in their own practice, and 49 and 61% did not know which reference values were used for adults and children,
respectively. Participants evaluated the survey as useful (average 74 points on a 0–100 scale) and would like more
case-based surveys concerning use of spirometry in the future (average 91 points).
Conclusion: In this cohort of self-selected GPs, probably more interested in respiratory medicine than the average
GP, we identified several problem areas and gaps in knowledge regarding the use of spirometry.
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Background
General practitioners (GPs) in Norway increasingly use
spirometry diagnostically as well as a tool to evaluate
lung function during follow up of patients with respira-
tory complaints. In 2018, approximately 97% of prac-
ticing GPs were reimbursed for performing spirometry
tests, on average 30 times, with a total cost of approxi-
mately 41.9 million Norwegian kroner [1].
Previous studies have found that GPs do not always
know when to request a spirometry, nor how to interpret
it. In a study from seven Norwegian GP offices during
2009/2010, patients with a record of asthma or chronic
obstructive pulmonary disease (COPD) were invited for
clinical examination and spirometry to validate their diag-
noses [2]. Of the 128 patients registered with COPD, only
74% fulfilled the spirometric criteria. Among the patients
clinically diagnosed with asthma, 17% were re-diagnosed
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with COPD. Similar results were found in a UK study
from 2017, where spirometries performed in primary care
were re-assessed by pulmonologists [3]. While 96% of
spirometry recordings were of adequate technical quality,
only 73% of spirometries from patients with a clinical
diagnosis of COPD were consistent with obstruction. A
recent case-based survey among 250 Swedish GPs con-
cluded that although the GPs indicated they would often
request a spirometry when appropriate, only 23% could
adequately interpret the spirometric recordings [4].
The Norwegian Organization for Quality Improvement
of Laboratory Examinations (Noklus) has provided qual-
ity systems for point-of-care laboratory testing in pri-
mary care since 1992 [5], including courses, site visits,
laboratory instrument evaluations, and external quality
assurance (EQA) schemes. The main aim of the present
study, conducted in collaboration with the Norwegian
GP Association and the Norwegian Respiratory Society,
was to investigate how GPs in Norway interpret a case
history and spirometry recordings of a patient with
COPD. A secondary aim was to investigate the GPs’
knowledge about their own spirometer.
Methods
In 2019, we distributed a web-based multiple-choice sur-
vey (Additional file 1) to the 4712 practicing GPs regis-
tered as members of the Norwegian GP Association,
with the following case history:
A previously healthy man in the age group 50-59
years presents with complaints of progressive breath-
lessness on physical exertion over the past year. He
has never had atopic symptoms, asthma or allergy,
and there is no family history of lung- or upper air-
way disorders. He started smoking in his late teens
but quit four years ago. You request a spirometry.
Do you include a reversibility test or not?
We asked which type of spirometer participants
used (see Additional file 1 for details), and pictures of
spirometry recordings were adapted accordingly to
ensure recognizability. Participants were asked for the
most likely diagnosis, and which spirometric parame-
ters they used to diagnose the disease and grade
airway obstruction. After choosing an answer, partici-
pants were immediately presented with the correct/
preferred answer, as well as updated references for
further reading. We also asked about general know-
ledge of their spirometer (need for calibration, refer-
ence values used), and some background information
(geographic region, number of patients served, num-
ber of spirometries usually requested during a regular
work week). Finally, we asked how useful they found
the survey and if they would like more surveys con-
cerning spirometry in the future.
The case history and spirometry recordings were of a
patient with COPD, which was the correct most likely
diagnosis. In line with the Norwegian Directorate of
Health’s guidelines on management of COPD [6], we
used the Global Initiative for Chronic Obstructive Lung
Disease (GOLD) criteria of postbronchodilator FEV1/
FVC ratio < 0.70 for diagnosis of COPD and FEV1 in %
of predicted to grade the airway obstruction (≥ 80%:
GOLD 1 – mild airway obstruction, 50–79%: GOLD 2 –
moderate airway obstruction, 30–49%: GOLD 3 – severe
airway obstruction, and < 30%: GOLD 4 - very severe air-
way obstruction) [7].
The survey was open exclusively to invited GPs for a
four-week period, and only responses collected during
this period were analyzed for the present study. After-
wards, a link to the survey was posted on Noklus’ web-
site [8]. Descriptive statistics were performed using R
version 3.6.1 [9]. Chi-square tests were used to investi-
gate differences between groups, and p-values < 0.05
were considered statistically significant.
Results
A total of 749 responses were collected during the four-
week period of data collection, partially or completely.
Participants spent on average 5–6 min on the survey.
Forty-two respondents indicated they were not currently
practicing GPs. Of the remaining, 47 responses were ex-
cluded because respondents had not answered the ques-
tion of the most likely diagnosis, and 30 because they
were not first-time responses (Fig. 1).
Four hundred sixty-seven participants (74%) indicated
they would request a reversibility test (Table 1), which
was considered the correct answer, since this was the
only option providing a post bronchodilator spirometry
which is required to diagnose COPD [6]. When pre-
sented with pre- and postbronchodilator spirometry re-
cordings, 582 (92%) correctly recognized that there was
no significant reversibility (Table 1). Five hundred twelve
participants (81%) correctly identified COPD as the most
likely diagnosis. Only 287 (46%) correctly indicated they
used only FEV1/FVC ratio for diagnosing COPD, and
269 (43%) correctly indicated they used only FEV1 in %
of predicted to grade the airway obstruction.
Welch-Allyn (Hill-rom Services Inc) and Spirare
(Diagnostica AS) were by far the most commonly used
spirometers, but 133 participants (21%) did not know
which type of spirometer was used in their practice
(these participants were provided with Spirare printouts
in the survey). The majority of participants indicated
they would request between one and four spirometries
per week, while 70 (11%) said they would request no spi-
rometries during a regular working week (Table 2). GPs
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who requested more spirometries per week or served
more patients, were more likely to recognize COPD as
the correct diagnosis (p-values for trend < 0.001 and
0.02, respectively), but these factors were not associated
with other outcomes. Type of spirometer used was gen-
erally not associated with performance in the survey
(Table 2).
Two hundred sixty-nine participants (43%) indicated
they did not know if, or how often, their spirometer
should be calibrated. Only 85 participants (13%) indi-
cated that they used the recommended Global Lung Ini-
tiative (GLI) reference values for adults, and 70
participants (11%) that they used the recommended GLI
reference values for children. 308 (49%) and 386 partici-
pants (61%) did not know which reference values were
reported by their spirometer for adults and children,
respectively.
Participants evaluated the survey as useful (average 74
points on a 0–100 scale, standard deviation (SD) 24
points) and would like more case-based surveys con-
cerning use of spirometry in the future (average 91
points, SD 17 points).
Discussion
We investigated how GPs in Norway would interpret a
case history and spirometry recordings of a patient with
COPD, as well as their knowledge about their own spir-
ometer. Most GPs were able to recognize a non-
significant reversibility test, and 81% correctly identified
COPD as the most likely diagnosis. Less than 50% of
GPs, however, were able to correctly identify the spiro-
metric parameters used to diagnose COPD and to grade
the airway obstruction. Many were unaware of which
type of spirometer and reference values were in use in
their practice.
Strengths and limitations
An important strength of our study is the broad recruit-
ment; the invitation was distributed through the mem-
bership records of the Norwegian GP Association. While
probably not 100% complete, this is the most updated
source of e-mail addresses for GPs in Norway. Still, the
low participation rate is a weakness of our study, limit-
ing our ability to draw general conclusions about spir-
ometry in general practice. Since there was self-selection
of GPs into the survey, there is reason to believe that
participating GPs, on average, were more interested in
respiratory medicine than non-participants. Conse-
quently, when we find knowledge gaps and problem
areas, we probably underestimate rather than overesti-
mate the challenges in this area for the GP population at
large. Also, the design of a cross-sectional survey means
we cannot draw inferences about cause and effect. Fi-
nally, as respondents were anonymous, a follow-up study
to asses learning effects of the survey cannot be per-
formed, leaving us only to speculate whether short
Fig. 1 Flow chart of participants
Tollånes et al. BMC Family Practice          (2020) 21:235 Page 3 of 6
surveys can be useful tools in continuous medical
education.
Current Norwegian COPD guidelines [6] are in line with
the GOLD recommendations, using post-bronchodilator
fixed ratio of FEV1/FVC < 0.7 to spirometrically define air-
way obstruction [7]. The fixed ratio is a choice of diagnos-
tic simplicity and may lead to misclassifications,
particularly overdiagnosis of COPD in the elderly, as the
FEV1/FVC ratio decreases with age [10]. A more accurate
definition of airway obstruction is FEV1/FVC ratio below
the lower 5th percentile observed in a healthy, relevant
population. Modern spirometers report this lower limit of
normal (LLN) as z-scores, as does a frequently used Nor-
wegian web-based decision support tool in COPD (www.
kolskalkulator.no). We did not include this parameter in
our survey, which may be added in future surveys.
Comparison to previous findings
Prevalence of COPD varies greatly between studies,
probably due to differences between populations and
diagnostic criteria used [11]. Both over- and under-
diagnosis of COPD likely happen in parallel. Over-
diagnosis of COPD is largely attributed to diagnosing
without performing the required spirometry [11]. In a
multi-center study from 20 countries, more than 60% of
patients who reported that they had been diagnosed with
COPD, did not have airflow obstruction on spirometry
[12]. In a Norwegian study, 26% of patients with a med-
ical record of COPD, did not fulfill the spirometric cri-
teria [2]. Similar findings were reported in a UK study
[3]. Underdiagnosing on the other hand, is mainly attrib-
uted to insufficient use of spirometry and missed diag-
nostic opportunities [11]. A retrospective UK study of
almost 40,000 patients with COPD, based on electronic
medical records from primary care, found that oppor-
tunities for diagnosis were missed in 85% of the patients
in the 5 years immediately preceding the diagnosis [13].
A Danish study found that opportunistic screening of
6700 at-risk patients in primary care identified that al-
most 18% had COPD [14]. In our survey, a premise was
that everyone requested a spirometry for our at-risk
patient. Therefore, we could not estimate potential
under- or over-diagnosis directly. However, our case his-
tory and spirometry recordings were designed to illus-
trate a textbook example of a COPD patient. In short,
our results showed that the knowledge on use and inter-
pretation of spirometry in Norwegian general practice
was suboptimal.
In Sweden, 250 GPs participated in a questionnaire-
based study to investigate knowledge about diagnosis
and treatment of COPD in general practice [4]. Spirom-
etry was frequently used, but only 23% of GPs correctly
interpreted the spirometry on the basis of postbroncho-
dilator parameters [4]. Our results were similar; less than
50% of GPs correctly identified spirometric parameters
used to 1) diagnose COPD, and to 2) grade airway ob-
struction. Only 143 of 630 (23%) correctly identified
both parameters.
Interpretation and implications
In our survey, we observed that requesting more spirome-
tries during a regular week, and serving more patients,
were factors associated with a higher chance of recogniz-
ing the correct diagnosis. This could be an indication that
requesting more spirometries improves interpretation
Table 1 Distribution of responses to survey
Question N responses (%)




Is there significant reversibility?
Yes 25 (4.0)
No 582 (92.4)
Don’t know 17 (2.7)
Missing 6 (1.0)
What is the most likely diagnosis?
No pulmonary disorder/healthy 18 (2.9)
Asthma 9 (1.4)
Restrictive pulmonary disorder 26 (8.9)
COPD 512 (81.3)
Other 10 (1.6)
Don’t know 25 (4.0)
Which parameter(s) did you use to diagnose COPD?
FVC 6 (1.0)
FVC in percent of predicted 11 (1.8)
FEV1 16 (2.5)
FEV1 in percent of predicted 32 (5.1)
FEV1/FVC ratio 287 (45.6)
FEV1/FVC ratio in percent of predicted 48 (7.6)
More than one option chosen 219 (34.8)
Missing 11 (1.8)
Which parameter(s) did you use to grade airway obstruction?
FVC 7 (1.1)
FVC in percent of predicted 19 (3.0)
FEV1 113 (17.9)
FEV1 in percent of predicted 269 (42.7)
FEV1/FVC ratio 75 (11.9)
FEV1/FVC ratio in percent of predicted 42 (6.7)
More than one option chosen 59 (9.4)
Missing 46 (7.3)
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skills or that GPs already competent in the use of spirom-
etry request more spirometries. We can similarly speculate
that serving more patients is associated with more experi-
ence and practice in this field, but we are not able to ex-
plore these matters further. There were no associations
between number of spirometries requested or patients
served and the other outcomes we examined, which, in
addition to the self-selection of GPs into the study, means
these observations must be interpreted with caution.
Efficient continuing medical educations on complex
health issues can be challenging in general practice. As a
follow up to the Swedish study [4], primary care centers
were later randomized to compare the impacts of two
types of continuing medical education designed to im-
prove GPs knowledge of COPD, either traditional lec-
tures or a case-based method, both consisting of two 2-h
sessions within 3 months. Compared with a reference
group, both interventions gave only marginal
improvements in the GPs knowledge measured after 12
months [15]. Others have found at least short-term posi-
tive effects of educational interventions when used in
combination (short lectures, case discussions, spirometry
workshops, inhalation demonstrations) [16, 17]. Our sur-
vey is now available online as a “mini-course” of spirom-
etry in COPD, an easily accessible resource for GPs in
need of a quick repetition. The participants evaluated
our survey as useful and said they would like more case-
based surveys concerning the use of spirometry in the
future. Thus, to offer an online repository of “mini-
courses” in spirometry is a goal. Since respondents
undertook the survey anonymously, a rigorous and long-
term investigation of any learning effects of such a sur-
vey is not possible at present.
Spirometry recordings contain a large number of pa-
rameters that are not necessary for correct interpretation
in general practice. Our results confirm that there is
Table 2 Performance in survey (number (and fraction) of correct answers) by type of spirometer used, number of spirometries












FEV11 in % of predicted
Type of spirometer used
Welch-Allyn (n = 311) 231 (0.75) 288 (0.93) 252 (0.81) 167 (0.54) 124 (0.40)
Spirare (n = 169) 129 (0.76) 159 (0.94) 143 (0.85) 69 (0.41) 80 (0.47)
Other/Don’t know (n =
150)
107 (0.72) 135 (0.90) 117 (0.78) 51 (0.34) 65 (0.43)
p-value for difference, all
groups




0.70 0.54 0.33 0.01 0.11
Number of spirometries requested per week
None (n = 70) 53 (0.76) 64 (0.91) 48 (0.69) 32 (0.46) 29 (0.41)
1–4 (n = 403) 308 (0.77) 383 (0.95) 358 (0.89) 193 (0.48) 203 (0.50)
5 or more (n = 30) 27 (0.90) 29 (0.97) 29 (0.97) 19 (0.63) 15 (0.50)
Missing (n = 127) 79 (0.63) 106 (0.84) 77 (0.61) 43 (0.34) 22 (0.17)
p-value for difference, all
groups
< 0.01 < 0.001 < 0.001 0.01 < 0.001
p-value for trend, excluding
“Missing”
0.23 0.20 < 0.001 0.20 0.25
Number of patients served by GP
< 1000 (n = 181) 142 (0.79) 167 (0.92) 148 (0.82) 88 (0.49) 93 (0.51)
1000–1499 (n = 294) 221 (0.75) 284 (0.97) 259 (0.89) 142 (0.48) 147 (0.50)
≥ 1500 (n = 33) 27 (0.82) 33 (1.00) 31 (0.94) 17 (0.52) 11 (0.33)
Missing (n = 122) 77 (0.64) 98 (0.80) 74 (0.61) 40 (0.33) 18 (0.15)
p-value for difference, all
groups
0.02 < 0.001 < 0.001 0.02 < 0.001
p-value for trend, excluding
“Missing”
0.88 0.75 0.02 0.67 0.12
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substantial confusion among GPs on which parameters
to use. Therefore, more user-friendly spirometry soft-
ware which displays and highlights important parame-
ters and suppresses parameters of less importance, could
perhaps also improve spirometry interpretation in gen-
eral practice.
Conclusion
We conducted a web-based survey, now available online
as a “mini-course”, and identified knowledge gaps and
problem areas in requesting and interpreting spirometry
in Norwegian general practice. Whether such short on-
line courses may be a useful resource to help improve
lung disorder management in general practice, may be a
future topic of investigation.
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